Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company carries out wholesale trade in pharmaceutical goods.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,991 | 4,898 | 5,621 | 8,939 | 6,782 | 2,353 | 2,844 | -9.0% |
| Total COGS | 2,911 | 3,284 | 3,942 | 5,955 | 4,274 | 697 | 854 | -18.5% |
| Gross Profit | 2,080 | 1,614 | 1,679 | 2,984 | 2,508 | 1,656 | 1,990 | -0.7% |
| Gross Margin | 41.7% | 33.0% | 29.9% | 33.4% | 37.0% | 70.4% | 70.0% | |
| 2,096 | 1,434 | 1,739 | 3,851 | 2,877 | 891 | 854 | -13.9% | |
| EBITDA | 16 | 180 | 60 | 867 | 369 | 764 | 1,136 | nmf |
| EBITDA Margin | 0.3% | 3.7% | 1.1% | 9.7% | 5.4% | 32.5% | 39.9% | |
| Total D&A | 18 | 13 | 11 | 11 | 15 | 6 | 6 | -16.0% |
| EBIT / Operating Income | 34 | 167 | 70 | 878 | 385 | 759 | 1,130 | nmf |
| 94 | 850 | 886 | 767 | 2 | 63 | 117 | +3.6% | |
| Profit Before Tax | 128 | 683 | 815 | 111 | 383 | 822 | 1,013 | nmf |
| Total Income Tax | 14 | 0 | 106 | 0 | 0 | 0 | 0 | +176.3% |
| Net Profit / (Loss) | 142 | 683 | 709 | 111 | 383 | 822 | 1,013 | nmf |
| Net Margin | 2.8% | 14.0% | 12.6% | 1.2% | 5.6% | 34.9% | 35.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →